Dr. Adina Kalet Selected for 2023 Hubbard Award
Dr. Adina Luba Kalet Selected as NBME’s 2023 John P. Hubbard Award Recipient
April 03, 2023 09:15 ET | NBME
PHILADELPHIA, April 03, 2023 (GLOBE NEWSWIRE) -- Adina Luba Kalet, MD, MPH, FACP, FAACH, was selected as the recipient of NBME’s 2023 John P. Hubbard Award in recognition of her extensive...
Lexington Announces First Multicenter Clinical Study Site
August 21, 2018 09:00 ET | Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Actinium Pharmaceuti
Actinium Pharmaceuticals Announces Treatment of First Patient in Novel Combination Trial of Actimab-A Plus CLAG-M
June 13, 2018 08:00 ET | Actinium Pharmaceuticals
- Trial supports Actinium’s strategic expansion of its CD33 program into novel combinations that can lead to increased use of bone marrow transplants and expand the addressable patient population for...